• レポートコード:QY20ST-09883 • 出版社/出版日:QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、134ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医療機器・消耗品 |
Single User | ¥560,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥840,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の糖尿病用注射ペン市場について種類別(再利用可能ペン、使い捨てペン)、用途別(Hospital Pharmacy、 Retail Pharmacy、 Online Sales、 Diabetes Clinics/ Centers)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・糖尿病用注射ペン市場の概要 ・世界の主要地域別糖尿病用注射ペン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の糖尿病用注射ペン市場規模2015-2026:種類別(再利用可能ペン、使い捨てペン) ・世界の糖尿病用注射ペン市場規模2015-2026:用途別(Hospital Pharmacy、 Retail Pharmacy、 Online Sales、 Diabetes Clinics/ Centers) ・糖尿病用注射ペンの北米市場規模2015-2020 ・糖尿病用注射ペンのヨーロッパ市場規模2015-2020 ・糖尿病用注射ペンの中国市場規模2015-2020 ・糖尿病用注射ペンの日本市場規模2015-2020 ・糖尿病用注射ペンの東南アジア市場規模2015-2020 ・糖尿病用注射ペンのインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・糖尿病用注射ペンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・糖尿病用注射ペンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Diabetic Injection Pen Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Diabetic Injection Pen market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Diabetic injection pen are used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Diabetic Injection Pen market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Diabetic Injection Pen industry.
Based on our recent survey, we have several different scenarios about the Diabetic Injection Pen YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Diabetic Injection Pen will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Diabetic Injection Pen market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Diabetic Injection Pen market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Diabetic Injection Pen market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Diabetic Injection Pen market. The report also includes nautical information, where it shows Diabetic Injection Pen market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Diabetic Injection Pen market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Diabetic Injection Pen market.
Geographical Analysis:
Based on region, the global Diabetic Injection Pen market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Diabetic Injection Pen market are
Novo Nordisk A/S
Eli Lilly and Company
AstraZeneca Plc
Biocon Ltd.
Sanofi S.A.
Becton,Dickinson and Company
Owen Mumford Ltd.
Jiangsu Delfu Co.
Wockhardt Ltd.
Segment by Type
Reusable Pens
Disposable Pens
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Sales
Diabetes Clinics/ Centers
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Diabetic Injection Pen market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Diabetic Injection Pen market.
• The market share of the global Diabetic Injection Pen market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Diabetic Injection Pen market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Diabetic Injection Pen market.
1 Diabetic Injection Pen Market Overview
1.1 Diabetic Injection Pen Product Scope
1.2 Diabetic Injection Pen Segment by Type
1.2.1 Global Diabetic Injection Pen Sales by Type (2020-2026)
1.2.2 Reusable Pens
1.2.3 Disposable Pens
1.3 Diabetic Injection Pen Segment by Application
1.3.1 Global Diabetic Injection Pen Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Diabetes Clinics/ Centers
1.4 Diabetic Injection Pen Market Estimates and Forecasts (2015-2026)
1.4.1 Global Diabetic Injection Pen Sales Growth Rate (2015-2026)
1.4.2 Global Diabetic Injection Pen Revenue and Growth Rate (2015-2026)
1.4.3 Global Diabetic Injection Pen Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Diabetic Injection Pen Industry Impact
1.5.1 How the Covid-19 is Affecting the Diabetic Injection Pen Industry
1.5.1.1 Diabetic Injection Pen Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Diabetic Injection Pen Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Diabetic Injection Pen Players to Combat Covid-19 Impact
2 Diabetic Injection Pen Estimate and Forecast by Region
2.1 Global Diabetic Injection Pen Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Diabetic Injection Pen Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Diabetic Injection Pen Sales Market Share by Region (2015-2020)
2.2.2 Global Diabetic Injection Pen Revenue Market Share by Region (2015-2020)
2.3 Global Diabetic Injection Pen Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Diabetic Injection Pen Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Diabetic Injection Pen Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Diabetic Injection Pen Estimates and Projections (2015-2026)
2.4.2 Europe Diabetic Injection Pen Estimates and Projections (2015-2026)
2.4.3 China Diabetic Injection Pen Estimates and Projections (2015-2026)
2.4.4 Japan Diabetic Injection Pen Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Diabetic Injection Pen Estimates and Projections (2015-2026)
2.4.6 India Diabetic Injection Pen Estimates and Projections (2015-2026)
3 Global Diabetic Injection Pen Competition Landscape by Players
3.1 Global Top Diabetic Injection Pen Players by Sales (2015-2020)
3.2 Global Top Diabetic Injection Pen Players by Revenue (2015-2020)
3.3 Global Diabetic Injection Pen Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Injection Pen as of 2019)
3.4 Global Diabetic Injection Pen Average Price by Company (2015-2020)
3.5 Manufacturers Diabetic Injection Pen Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Diabetic Injection Pen Players (Opinion Leaders)
4 Global Diabetic Injection Pen Market Size by Type
4.1 Global Diabetic Injection Pen Historic Market Review by Type (2015-2020)
4.1.1 Global Diabetic Injection Pen Sales Market Share by Type (2015-2020)
4.1.2 Global Diabetic Injection Pen Revenue Market Share by Type (2015-2020)
4.1.3 Global Diabetic Injection Pen Price by Type (2014-2020)
4.2 Global Diabetic Injection Pen Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Diabetic Injection Pen Sales Forecast by Type (2021-2026)
4.2.2 Global Diabetic Injection Pen Revenue Forecast by Type (2021-2026)
4.2.3 Global Diabetic Injection Pen Price Forecast by Type (2021-2026)
5 Global Diabetic Injection Pen Market Size by Application
5.1 Global Diabetic Injection Pen Historic Market Review by Application (2015-2020)
5.1.1 Global Diabetic Injection Pen Sales Market Share by Application (2015-2020)
5.1.2 Global Diabetic Injection Pen Revenue Market Share by Application (2015-2020)
5.1.3 Global Diabetic Injection Pen Price by Application (2015-2020)
5.2 Global Diabetic Injection Pen Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Diabetic Injection Pen Sales Forecast by Application (2021-2026)
5.2.2 Global Diabetic Injection Pen Revenue Forecast by Application (2021-2026)
5.2.3 Global Diabetic Injection Pen Price Forecast by Application (2021-2026)
3 North America Diabetic Injection Pen Market Facts & Figures
3.2 North America Diabetic Injection Pen Sales Market Share by Company (2015-2020)
3.3 North America Diabetic Injection Pen Sales Market Share by Type (2015-2020)
3.4 North America Diabetic Injection Pen Sales Market Share by Application (2015-2020)
4 Europe Diabetic Injection Pen Market Facts & Figures
4.2 Europe Diabetic Injection Pen Sales Market Share by Company (2015-2020)
4.3 Europe Diabetic Injection Pen Sales Market Share by Type (2015-2020)
4.4 Europe Diabetic Injection Pen Sales Market Share by Application (2015-2020)
5 China Diabetic Injection Pen Market Facts & Figures
5.2 China Diabetic Injection Pen Sales Market Share by Company (2015-2020)
5.3 China Diabetic Injection Pen Sales Market Share by Type (2015-2020)
5.4 China Diabetic Injection Pen Sales Market Share by Application (2015-2020)
6 Japan Diabetic Injection Pen Market Facts & Figures
6.2 Japan Diabetic Injection Pen Sales Market Share by Company (2015-2020)
6.3 Japan Diabetic Injection Pen Sales Market Share by Type (2015-2020)
6.4 Japan Diabetic Injection Pen Sales Market Share by Application (2015-2020)
7 Southeast Asia Diabetic Injection Pen Market Facts & Figures
7.2 Southeast Asia Diabetic Injection Pen Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Diabetic Injection Pen Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Diabetic Injection Pen Sales Market Share by Application (2015-2020)
8 India Diabetic Injection Pen Market Facts & Figures
8.2 India Diabetic Injection Pen Sales Market Share by Company (2015-2020)
8.3 India Diabetic Injection Pen Sales Market Share by Type (2015-2020)
8.4 India Diabetic Injection Pen Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Diabetic Injection Pen Business
12.1 Novo Nordisk A/S
12.1.1 Novo Nordisk A/S Diabetic Injection Pen Corporation Information
12.1.2 Novo Nordisk A/S Diabetic Injection Pen Business Overview and Total Revenue
12.1.3 Novo Nordisk A/S Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk A/S Diabetic Injection Pen Products Offered
12.1.5 Novo Nordisk A/S Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Diabetic Injection Pen Corporation Information
12.2.2 Eli Lilly and Company Diabetic Injection Pen Business Overview and Total Revenue
12.2.3 Eli Lilly and Company Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lilly and Company Diabetic Injection Pen Products Offered
12.2.5 Eli Lilly and Company Recent Development
12.3 AstraZeneca Plc
12.3.1 AstraZeneca Plc Diabetic Injection Pen Corporation Information
12.3.2 AstraZeneca Plc Diabetic Injection Pen Business Overview and Total Revenue
12.3.3 AstraZeneca Plc Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AstraZeneca Plc Diabetic Injection Pen Products Offered
12.3.5 AstraZeneca Plc Recent Development
12.4 Biocon Ltd.
12.4.1 Biocon Ltd. Diabetic Injection Pen Corporation Information
12.4.2 Biocon Ltd. Diabetic Injection Pen Business Overview and Total Revenue
12.4.3 Biocon Ltd. Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Biocon Ltd. Diabetic Injection Pen Products Offered
12.4.5 Biocon Ltd. Recent Development
12.5 Sanofi S.A.
12.5.1 Sanofi S.A. Diabetic Injection Pen Corporation Information
12.5.2 Sanofi S.A. Diabetic Injection Pen Business Overview and Total Revenue
12.5.3 Sanofi S.A. Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi S.A. Diabetic Injection Pen Products Offered
12.5.5 Sanofi S.A. Recent Development
12.6 Becton,Dickinson and Company
12.6.1 Becton,Dickinson and Company Diabetic Injection Pen Corporation Information
12.6.2 Becton,Dickinson and Company Diabetic Injection Pen Business Overview and Total Revenue
12.6.3 Becton,Dickinson and Company Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Becton,Dickinson and Company Diabetic Injection Pen Products Offered
12.6.5 Becton,Dickinson and Company Recent Development
12.7 Owen Mumford Ltd.
12.7.1 Owen Mumford Ltd. Diabetic Injection Pen Corporation Information
12.7.2 Owen Mumford Ltd. Diabetic Injection Pen Business Overview and Total Revenue
12.7.3 Owen Mumford Ltd. Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Owen Mumford Ltd. Diabetic Injection Pen Products Offered
12.7.5 Owen Mumford Ltd. Recent Development
12.8 Jiangsu Delfu Co.
12.8.1 Jiangsu Delfu Co. Diabetic Injection Pen Corporation Information
12.8.2 Jiangsu Delfu Co. Diabetic Injection Pen Business Overview and Total Revenue
12.8.3 Jiangsu Delfu Co. Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Jiangsu Delfu Co. Diabetic Injection Pen Products Offered
12.8.5 Jiangsu Delfu Co. Recent Development
12.9 Wockhardt Ltd.
12.9.1 Wockhardt Ltd. Diabetic Injection Pen Corporation Information
12.9.2 Wockhardt Ltd. Diabetic Injection Pen Business Overview and Total Revenue
12.9.3 Wockhardt Ltd. Diabetic Injection Pen Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Wockhardt Ltd. Diabetic Injection Pen Products Offered
12.9.5 Wockhardt Ltd. Recent Development
13 Diabetic Injection Pen Manufacturing Cost Analysis
13.1 Diabetic Injection Pen Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Diabetic Injection Pen
13.4 Diabetic Injection Pen Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Diabetic Injection Pen Distributors List
14.3 Diabetic Injection Pen Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Diabetic Injection Pen Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Diabetic Injection Pen Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Diabetic Injection Pen Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Diabetic Injection Pen Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Diabetic Injection Pen Players to Combat Covid-19 Impact
Table 8. Global Market Diabetic Injection Pen Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Diabetic Injection Pen Sales (K Units) by Region (2015-2020)
Table 10. Global Diabetic Injection Pen Sales Market Share by Region (2015-2020)
Table 11. Global Diabetic Injection Pen Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Diabetic Injection Pen Revenue Share by Region (2015-2020)
Table 13. Global Diabetic Injection Pen Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Diabetic Injection Pen Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Diabetic Injection Pen Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Diabetic Injection Pen Revenue Share Forecast by Region (2021-2026)
Table 17. Global Diabetic Injection Pen (K Units) of Key Companies (2015-2020)
Table 18. Global Diabetic Injection Pen Sales Share by Company (2015-2020)
Table 19. Global Diabetic Injection Pen Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Diabetic Injection Pen Revenue Share by Company (2015-2020)
Table 21. Global Diabetic Injection Pen by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Injection Pen as of 2019)
Table 22. Global Diabetic Injection Pen Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Diabetic Injection Pen Manufacturing Sites and Area Served
Table 24. Manufacturers Diabetic Injection Pen Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Diabetic Injection Pen Players
Table 27. Global Diabetic Injection Pen Sales (K Units) by Type (2015-2020)
Table 28. Global Diabetic Injection Pen Sales Share by Type (2015-2020)
Table 29. Global Diabetic Injection Pen Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Diabetic Injection Pen Price (K Units) by Type (2015-2020)
Table 31. Global Diabetic Injection Pen Sales Share by Type (2021-2026)
Table 32. Global Diabetic Injection Pen Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Diabetic Injection Pen Revenue Share by Type (2021-2026)
Table 34. Global Diabetic Injection Pen Price (K Units) by Type (2021-2026)
Table 35. Global Diabetic Injection Pen Sales (K Units) by Application (2015-2020)
Table 36. Global Diabetic Injection Pen Sales Share by Application (2015-2020)
Table 37. Global Diabetic Injection Pen Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Diabetic Injection Pen Price (K Units) by Application (2015-2020)
Table 39. Global Diabetic Injection Pen Sales (K Units) by Application (2021-2026)
Table 40. Global Diabetic Injection Pen Sales Share by Application (2021-2026)
Table 41. Global Diabetic Injection Pen Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Diabetic Injection Pen Revenue Share by Application (2021-2026)
Table 43. Global Diabetic Injection Pen Price (K Units) by Application (2021-2026)
Table 44. United States Diabetic Injection Pen Sales (K Units) by Company (2015-2020)
Table 45. United States Diabetic Injection Pen Sales Market Share by Company (2015-2020)
Table 46. United States Diabetic Injection Pen Sales (K Units) by Type (2015-2020)
Table 47. United States Diabetic Injection Pen Sales Market Share by Type (2015-2020)
Table 48. United States Diabetic Injection Pen Sales (K Units) by Application (2015-2020)
Table 49. United States Diabetic Injection Pen Sales Market Share by Application (2015-2020)
Table 50. Europe Diabetic Injection Pen Sales (K Units) by Company (2015-2020)
Table 51. Europe Diabetic Injection Pen Sales Market Share by Company (2015-2020)
Table 52. Europe Diabetic Injection Pen Sales (K Units) by Type (2015-2020)
Table 53. Europe Diabetic Injection Pen Sales Market Share by Type (2015-2020)
Table 54. Europe Diabetic Injection Pen Sales (K Units) by Application (2015-2020)
Table 55. Europe Diabetic Injection Pen Sales Market Share by Type (2015-2020)
Table 56. China Diabetic Injection Pen Sales (K Units) by Company (2015-2020)
Table 57. China Diabetic Injection Pen Sales Market Share by Company (2015-2020)
Table 58. China Diabetic Injection Pen Sales (K Units) by Type (2015-2020)
Table 59. China Diabetic Injection Pen Sales Market Share by Type (2015-2020)
Table 60. China Diabetic Injection Pen Sales (K Units) by Application (2015-2020)
Table 61. China Diabetic Injection Pen Sales Market Share by Application (2015-2020)
Table 62. Japan Diabetic Injection Pen Sales (K Units) by Company (2015-2020)
Table 63. Japan Diabetic Injection Pen Sales Market Share by Company (2015-2020)
Table 64. Japan Diabetic Injection Pen Sales (K Units) by Type (2015-2020)
Table 65. Japan Diabetic Injection Pen Sales Market Share by Type (2015-2020)
Table 66. Japan Diabetic Injection Pen Sales (K Units) by Application (2015-2020)
Table 67. Japan Diabetic Injection Pen Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Diabetic Injection Pen Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Diabetic Injection Pen Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Diabetic Injection Pen Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Diabetic Injection Pen Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Diabetic Injection Pen Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Diabetic Injection Pen Sales Market Share by Application (2015-2020)
Table 74. India Diabetic Injection Pen Sales (K Units) by Company (2015-2020)
Table 75. India Diabetic Injection Pen Sales Market Share by Company (2015-2020)
Table 76. India Diabetic Injection Pen Sales (K Units) by Type (2015-2020)
Table 77. India Diabetic Injection Pen Sales Market Share by Type (2015-2020)
Table 78. India Diabetic Injection Pen Sales (K Units) by Application (2015-2020)
Table 79. India Diabetic Injection Pen Sales Market Share by Application (2015-2020)
Table 80. Novo Nordisk A/S Corporation Information
Table 81. Novo Nordisk A/S Description and Business Overview
Table 82. Novo Nordisk A/S Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novo Nordisk A/S Diabetic Injection Pen Product
Table 84. Novo Nordisk A/S Recent Development
Table 85. Eli Lilly and Company Corporation Information
Table 86. Eli Lilly and Company Description and Business Overview
Table 87. Eli Lilly and Company Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eli Lilly and Company Diabetic Injection Pen Product
Table 89. Eli Lilly and Company Recent Development
Table 90. AstraZeneca Plc Corporation Information
Table 91. AstraZeneca Plc Description and Business Overview
Table 92. AstraZeneca Plc Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. AstraZeneca Plc Diabetic Injection Pen Product
Table 94. AstraZeneca Plc Recent Development
Table 95. Biocon Ltd. Corporation Information
Table 96. Biocon Ltd. Description and Business Overview
Table 97. Biocon Ltd. Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Biocon Ltd. Diabetic Injection Pen Product
Table 99. Biocon Ltd. Recent Development
Table 100. Sanofi S.A. Corporation Information
Table 101. Sanofi S.A. Description and Business Overview
Table 102. Sanofi S.A. Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi S.A. Diabetic Injection Pen Product
Table 104. Sanofi S.A. Recent Development
Table 105. Becton,Dickinson and Company Corporation Information
Table 106. Becton,Dickinson and Company Description and Business Overview
Table 107. Becton,Dickinson and Company Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Becton,Dickinson and Company Diabetic Injection Pen Product
Table 109. Becton,Dickinson and Company Recent Development
Table 110. Owen Mumford Ltd. Corporation Information
Table 111. Owen Mumford Ltd. Description and Business Overview
Table 112. Owen Mumford Ltd. Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Owen Mumford Ltd. Diabetic Injection Pen Product
Table 114. Owen Mumford Ltd. Recent Development
Table 115. Jiangsu Delfu Co. Corporation Information
Table 116. Jiangsu Delfu Co. Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Jiangsu Delfu Co. Description and Business Overview
Table 118. Jiangsu Delfu Co. Diabetic Injection Pen Product
Table 119. Jiangsu Delfu Co. Recent Development
Table . Wockhardt Ltd. Corporation Information
Table . Wockhardt Ltd. Diabetic Injection Pen Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Wockhardt Ltd. Description and Business Overview
Table . Wockhardt Ltd. Diabetic Injection Pen Product
Table . Wockhardt Ltd. Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Diabetic Injection Pen Distributors List
Table 128. Diabetic Injection Pen Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetic Injection Pen Product Picture
Figure 2. Global Diabetic Injection Pen Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Diabetic Injection Pen Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacy Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Online Sales Examples
Figure 9. Diabetes Clinics/ Centers Examples
Figure 10. Global Diabetic Injection Pen Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Diabetic Injection Pen Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Diabetic Injection Pen Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Diabetic Injection Pen Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Diabetic Injection Pen Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Diabetic Injection Pen Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Diabetic Injection Pen Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Diabetic Injection Pen Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Diabetic Injection Pen Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Diabetic Injection Pen Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Diabetic Injection Pen Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Diabetic Injection Pen Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Diabetic Injection Pen Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Diabetic Injection Pen Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Diabetic Injection Pen Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Diabetic Injection Pen Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Diabetic Injection Pen Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Diabetic Injection Pen Players Market Share by Revenue in Diabetic Injection Pen 2015 & 2019
Figure 28. Diabetic Injection Pen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Diabetic Injection Pen Revenue Share by Type (2015-2020)
Figure 30. Global Diabetic Injection Pen Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Diabetic Injection Pen Revenue Share by Application (2015-2020)
Figure 32. Global Diabetic Injection Pen Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Diabetic Injection Pen Sales Market Share by Type in 2019
Figure 34. United States Diabetic Injection Pen Sales Market Share by Type in 2019
Figure 35. Europe Diabetic Injection Pen Sales Market Share by Company in 2019
Figure 36. Europe Diabetic Injection Pen Sales Market Share by Type in 2019
Figure 37. Europe Diabetic Injection Pen Sales Market Share by Application in 2019
Figure 38. China Diabetic Injection Pen Sales Market Share by Company in 2019
Figure 39. China Diabetic Injection Pen Sales Market Share by Type in 2019
Figure 40. China Diabetic Injection Pen Sales Market Share by Application in 2019
Figure 41. Japan Diabetic Injection Pen Sales Market Share by Company in 2019
Figure 42. Japan Diabetic Injection Pen Sales Market Share by Type in 2019
Figure 43. Japan Diabetic Injection Pen Sales Market Share by Application in 2019
Figure 44. Southeast Asia Diabetic Injection Pen Sales Market Share by Company in 2019
Figure 45. Southeast Asia Diabetic Injection Pen Sales Market Share by Type in 2019
Figure 46. Southeast Asia Diabetic Injection Pen Sales Market Share by Application in 2019
Figure 47. India Diabetic Injection Pen Sales Market Share by Company in 2019
Figure 48. India Diabetic Injection Pen Sales Market Share by Type in 2019
Figure 49. India Diabetic Injection Pen Sales Market Share by Application in 2019
Figure 50. Novo Nordisk A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Biocon Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Becton,Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Owen Mumford Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Jiangsu Delfu Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Wockhardt Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Diabetic Injection Pen
Figure 61. Manufacturing Process Analysis of Diabetic Injection Pen
Figure 62. Diabetic Injection Pen Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed